ExploreWatchlistsPricing
  1. JP-listed companies
  2. Kubota Pharmaceutical Holdings Co., Ltd.
  3. Financials
  4. Cash and cash equivalents

Kubota Pharmaceutical Holdings Co., Ltd. (4596)

Market cap
¥11.2B
P/E ratio
Kubota Pharmaceutical develops innovative eye disease treatments including wearable myopia devices and pharmaceuticals for conditions like diabetic retinopathy.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCash and cash equivalents (Million JPY)YoY (%)
Dec 31, 20251,919+31.87%
Dec 31, 20241,455-47.43%
Dec 31, 20232,768-31.65%
Dec 31, 20224,049+1.80%
Dec 31, 20213,977+56.97%
Dec 31, 20202,534-39.56%
Dec 31, 20194,192+435.60%
Dec 31, 2018783+2596.50%
Dec 31, 201729-97.22%
Dec 31, 20161,042+208394.80%
Dec 31, 20151

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat